MedCity News December 28, 2025
A new study found that continuous glucose monitors can cut healthcare costs by about 20% while also improving outcomes for insulin-dependent diabetes patients, largely by reducing hospitalizations and emergency department visits. Despite these benefits and broad insurance coverage, roughly 80% of eligible patients still are not using the technology — highlighting a significant adoption gap.
New research emerged this month shining light on the need for wider use of continuous glucose monitors (CGMs).
The study — which was conducted by CCS, a chronic care management company — analyzed data from nearly 940,000 patients and found that CGMs can cut healthcare costs by about 20% while also improving outcomes for diabetes patients who are insulin-dependent.
The cost savings come from lower...
Today's Sponsors
Today's Sponsor